当前位置:首页 - 行情中心 - 九洲药业(603456) - 财务分析 - 现金流量表

九洲药业

(603456)

  

流通市值:126.21亿  总市值:126.21亿
流通股本:8.89亿   总股本:8.89亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金1,307,660,128.524,374,804,746.483,453,155,260.412,222,642,259.36
收到的税费返还62,001,960.38364,683,646.39244,333,631.52167,973,404.23
收到其他与经营活动有关的现金156,249,280.2266,162,063.77249,989,022.39198,399,243.7
经营活动现金流入的平衡项目0000
经营活动现金流入小计1,525,911,369.15,005,650,456.643,947,477,914.322,589,014,907.29
购买商品、接受劳务支付的现金679,377,437.22,402,832,843.92,026,805,612.11,396,295,988.75
支付给职工以及为职工支付的现金282,203,478.06907,508,162.91692,809,474.01482,301,156.44
支付的各项税费105,463,911.62282,601,122.8251,140,433.29185,100,757.52
支付其他与经营活动有关的现金173,193,285.98421,053,152.96322,694,217.31205,792,904.89
经营活动现金流出的平衡项目0000
经营活动现金流出小计1,240,238,112.864,013,995,282.573,293,449,736.712,269,490,807.6
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额285,673,256.24991,655,174.07654,028,177.61319,524,099.69
二、投资活动产生的现金流量:
收回投资收到的现金2,153,846.1519,600,00010,331,360.34-
取得投资收益收到的现金-2,657,168.84--
处置固定资产、无形资产和其他长期资产收回的现金净额405,476.25,532,253.77979,062.75502,856
收到的其他与投资活动有关的现金-4,849,440.1242,094.54-
投资活动现金流入的平衡项目0000
投资活动现金流入小计2,559,322.3532,638,862.7311,352,517.63502,856
购建固定资产、无形资产和其他长期资产支付的现金177,560,791.29888,964,773.75743,490,718.64480,007,463.87
投资支付的现金-25,000,00015,000,00015,000,000
支付其他与投资活动有关的现金100,000,000---
投资活动现金流出的平衡项目0000
投资活动现金流出小计277,560,791.29913,964,773.75758,490,718.64495,007,463.87
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-275,001,468.94-881,325,911.02-747,138,201.01-494,504,607.87
三、筹资活动产生的现金流量:
取得借款收到的现金300,000,0001,627,052,534.161,627,052,534.161,571,949,063.23
收到其他与筹资活动有关的现金-300,000,000--
筹资活动现金流入平衡项目0000
筹资活动现金流入小计300,000,0001,927,052,534.161,627,052,534.161,571,949,063.23
偿还债务支付的现金295,848,313.911,627,690,0001,540,000,0001,540,000,000
分配股利、利润或偿付利息支付的现金1,854,267.19471,296,198.39459,904,025.1813,014,002.23
支付其他与筹资活动有关的现金1,837,440437,677,761.06104,931,967.17101,731,730.56
筹资活动现金流出平衡项目0000
筹资活动现金流出小计299,540,021.12,536,663,959.452,104,835,992.351,654,745,732.79
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额459,978.9-609,611,425.29-477,783,458.19-82,796,669.56
四、汇率变动对现金及现金等价物的影响4,137,864.9816,894,805.3-6,884,895.395,376,453.08
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额15,269,631.18-482,387,356.94-577,778,376.98-252,400,724.66
加:期初现金及现金等价物余额2,593,681,994.963,076,069,351.93,076,069,351.93,076,069,351.9
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额2,608,951,626.142,593,681,994.962,498,290,974.922,823,668,627.24
补充资料:
净利润-607,067,516.83-475,613,557.25
资产减值准备-218,481,518.23-26,268,486.77
固定资产和投资性房地产折旧-359,647,619.65-174,240,985.19
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-359,647,619.65-174,240,985.19
无形资产摊销-43,475,856.42-21,923,194.97
长期待摊费用摊销-2,582,039.97-1,148,755.84
处置固定资产、无形资产和其他长期资产的损失-3,156,554.9-2,811,070.01
固定资产报废损失-1,978,480.76-285,971.8
财务费用-5,862,553.61-8,749,999.36
投资损失-8,132,266.51-5,328,237.59
递延所得税--14,935,989.35-15,627,563.1
其中:递延所得税资产减少--934,141.66-492,302.79
递延所得税负债增加--14,001,847.69-15,135,260.31
存货的减少--121,125,160.27-111,932,674.29
经营性应收项目的减少--301,874,023.71--432,765,476.42
经营性应付项目的增加-148,134,222.24--120,211,418.04
其他-6,949,340.52-3,128,696.86
现金的期末余额-2,593,681,994.96-2,823,668,627.24
减:现金的期初余额-3,076,069,351.9-3,076,069,351.9
公告日期2025-04-152025-04-112024-10-252024-08-27
审计意见(境内)标准无保留意见
TOP↑